Article
Diffuse large B-cell lymphoma patient-derived xenograft models capture the molecular and biological heterogeneity of the disease.
Blood - 5 May 2016
Chapuy Bjoern, Cheng Hongwei, Watahiki Akira, Ducar Matthew D, Tan Yuxiang, Chen Linfeng, Roemer Margaretha G M, Ouyang Jing, Christie Amanda L, Zhang Liye, Gusenleitner Daniel, Abo Ryan P, Farinha Pedro, von Bonin Frederike, Thorner Aaron R, Sun Heather H, Gascoyne Randy D, Pinkus Geraldine S, van Hummelen Paul, Wulf Gerald G, Aster Jon C, Weinstock David M, Monti Stefano, Rodig Scott J, Wang Yuzhuo, Shipp Margaret A
Abstract excerpt
Diffuse large B-cell lymphoma (DLBCL) is a heterogeneous disease defined by transcriptional classifications, specific signaling and survival pathways, and multiple low-frequency genetic alterations. Preclinical model systems that capture the genetic and functional heterogeneity of DLBCL are urgently needed. Here, we generated and characterized a panel of large B-cell lymphoma (LBCL) patient-derived xenograft...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
